LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...
In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...
7d
FOX 9 Minneapolis-St. Paul on MSNPrime Therapeutics ordered to pay $10 million for price fixingEagan-based Prime Therapeutics has been ordered to pay $10 million in damages after federal arbitration found it engaged in ...
"Prime demonstrated how actual patients saved on prescription drugs as a result of the agreement [between Prime and Express Scripts, Inc. ('ESI')]. With this ruling, AHF is seeking to rewind the clock ...
Arbitrator issued interim award and Injunction to prevent future wrongdoing by Prime Therapeutics in antitrust case brought by AIDS Healthcare Foundation Regarding AHF's arbitration victory over ...
A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits manager ...
According to Reuters, the grocery retailer notified Express Scripts in September 2022 of its plan to terminate the pharmacy ...
Arbitrator issues interim award and Injunction to prevent future wrongdoing by Prime Therapeutics in antitrust case brought by AIDS Healthcare Foundation In a ruling Friday, January 17 ...
Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...
In a report released today, Uy Ear from Mizuho Securities maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report), with a price target of $9.00. The company’s shares closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results